NCT04756817View on ClinicalTrials.gov

Immunogenicity of the BNT162b2 Covid-19 Vaccine in Elderly People Aged 85 and Older in Greece

CompletedOBSERVATIONAL
Enrollment

297

Participants

Timeline

Start Date

February 13, 2021

Primary Completion Date

August 30, 2021

Study Completion Date

September 30, 2021

Conditions
Immunogenicity, Vaccine
Trial Locations (1)

54635

G. Gennimatas General Hospital, Thessaloniki

All Listed Sponsors
collaborator

Aristotle University Of Thessaloniki

OTHER

lead

G.Gennimatas General Hospital

OTHER

NCT04756817 - Immunogenicity of the BNT162b2 Covid-19 Vaccine in Elderly People Aged 85 and Older in Greece | Biotech Hunter | Biotech Hunter